All AbMole products are for research use only, cannot be used for human consumption.
GSK2982772 is a potent inhibitor of selective receptor interaction protein kinase 1 (RIPK1), with IC50 values of 16 nM and 20 nM for human and monkey RIP1, respectively. GSK2982772 binds effectively to RIP1, has sensitive kinase specificity, and has excellent activity in blocking many TNF-dependent cellular responses. RIP1 is an important upstream kinase that has been shown to regulate inflammation through specific functions of scaffold and kinase. In vivo, GSK2982772 showed good free fractions in the blood of rats (4.2%), dogs (11%), cynomolgus monkeys (11%), and humans (7.4%).
Patent. US2024024368A1 2024-12-19.
Patent. US2024024368A1
GSK2982772 purchased from AbMole
Patent. US2024024368A1 2024 Dec 19; .
Patent. US2024024368A1
GSK2982772 purchased from AbMole
| Molecular Weight | 377.40 |
| Formula | C20H19N5O3 |
| CAS Number | 1622848-92-3 |
| Solubility (25°C) | DMSO ≥ 60 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Necroptosis Products |
|---|
| GW806742X
GW806742X is an ATP site-targeing kinase inhibitor (IC50 in nM = 2/VEGFR2, 15/SRC, 47/C-FMS, 851/GSK3, 9016/ERBB2, 9120/FGFR) with potent antiproliferation activity against cancer cultures (IC50 in nM = 5/HUVEC-v, 424/HUVEC-b, 81/HEF, 453/MDA468, 470/A375P, 693/HT29, 734/PC3), GW806742X is now better known as Compound 1 for its anti-necroptosis activity via affinity interaction with ML |
| Necrosulfonamide
Necrosulfonamide is a necroptosis inhibitor which selectively targeting the mixed lineage kinase domain-like protein (MLKL) with IC50 value of 124 nM in human HT-29. Necrosulfonamide prevents MLKL-RIP1-RIP3 necrosome complex from interacting with its downstream effectors. |
| GSK547
GSK547 is a potent and highly selective inhibitor of receptor-interacting protein kinase 1 (RIPK1) and also inhibits necroptosis. |
| PK68
PK68 is a potent and selective type II RIPK1 inhibitor with an IC50 value of approximately 90 nM that inhibits RIPK1-dependent necroptosis. It can be used in studies related to inflammatory diseases and cancer metastasis. |
| GSK-843
GSK-843 is a potent receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 8.6 nM, and inhibits kinase activity with an IC50 of 6.5 nM. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
